The ionophores A23187 and X-537A were used as probes to investigate the possible role of calcium uptake by bone as a mediator for the stimulation of bone resorption induced by parathyroid hormone (PTH) and other agents in cultured mouse calvaria. The ionophores alone at concentrations from 1 nM to 20 muM did not stimulate bone resorption, nor did they potentiate bone resorption stimulated by submaximal concentrations of PTH after either brief (15-60 min) or extended (1-3 day) exposure to the ionophores. Unexpectedly, we found that the ionophores inhibit in a dose-dependent manner bone resorption stimulated by PTH and a wide variety of other compounds (prostaglandin E2, 1alpha-hydroxycholecalciferol, 3-isobutyl-1-methyl-xanthine, and phorbol myristate acetate). This inhibition was not due to irreversible damage to the bones by the ionophores, because the inhibition was reversible even after 24 h of treatment. Inhibition of bone resorption by the ionophores was observed in media of both high and low calcium concentration, indicating that the inhibition was not due to a critical extracellular calcium concentration. Inhibition by the ionophores differs qualitatively in several ways from that produced by calcitonin, a natural inhibitor of bone resorption. Furthermore, A23187 at 1.0 mug/ml had no effect on the accumulation of cyclic AMP in the medium of either control, PTH-or calcitonin treated calvaria. We conclude that the ionophores A23187 or […] 
INTRODUCTION
It has been proposed (1) that cytosol calcium ion concentration regulates a number of physiological processes. Divalent cation ionophores with relatively high selectivity for calcium ion have been used in several systems to demonstrate the involvement of calcium ion in the action of physiological stimuli (2) (3) (4) (5) . Because these ionophores either mimic (2) (3) (4) or potentiate (5) a physiological stimulus in several systems, we have investigated the effect of the cation ionophores A23187 (6) and X-537A (7) on bone resorption in mouse calvaria in organ culture.
The possibility that calcium ion may be involved in stimulating bone resorption was initially suggested by the report of Parsons et al. (8) that intravenous injection of parathyroid hormone (PTH)l in dogs produced a small, but significant, transient decrease in plasma calcium concentration. Both in vivo (9) and in vitro (10, 11) experiments have suggested that this decrease in plasma calcium is due to an accumulation of the ion in bone. These findings led Parsons and his co-workers to hypothesize that calcium uptake by bone is one of the earliest actions of PTH on this target tissue (8, 9) . However, our results indicate that instead of mimicking or potentiating the effects of stimulators of bone resorption, these ionophores potently inhibit bone resorption, stimulated by all of the compounds with which they have been tested.
METHODS
Organ culture of bone. The method used was essentially that described previously (12) , based on the procedure of Goldhaber (13) .2 At 4-5 days of age, calvaria (frontal and parietal bones) were removed from the mice under aseptic conditions and fixed to sterile cover slips with a clot formed by mixing chick embryo extract and rooster plasma (1:2, vol/vol). The cover slip and attached calvarium were transferred to a Leighton tube and incubated at 37°C in a rotating drum (0.2 rpm). Each tube contained 2.0 ml of Oxman's modification of Eagle's minimal essential medium, supplemented with 5 mg/ml bovine serum albumin (BSA medium) or with 15% (vol/vol) heat-inactivated (56°C, 60 min) horse serum and 2.5% (vol/vol) heat-inactivated fetal calf serum (heat-inactivated serum medium), 100 ug/ml streptomycin sulfate, 100 U/ml sodium penicillin G, and 10 U/ml sodium heparin. The tubes were gassed with 50% 02, 5% C02, 45% N2, and sealed with a silicone stopper.
In the standard experimental protocol, the bones were incubated for the first 24 h in culture without any treatment, the medium was removed for determination of calcium concentration (the washout sample), 2.0 ml of fresh medium containing the indicated test substances was added, and the tubes were gassed and resealed as described above. Incubation was continued for an additional 48-72 h. A 0.2-ml aliquot of medium was removed for calcium determination, and the tubes were regassed at 24-h intervals.
Measurements of bone resorption. Resorption of bone involves release of the extracellular mineral and degradation of the organic phase of this tissue. Indices used to evaluate bone resorption in vitro include morphological examination of microcinematography (14) , morphological scoring of the extent of resorption (12, 15) , release from bone of previously incorporated 45Ca (12, (16) (17) (18) , increase in total medium calcium (40Ca) concentration due to release of calcium from the bone (17, 19) , and release of hydroxyproline as an indication of collagen degradation (20) . We have found that determination of total medium calcium concentration is more convenient, faster, and considerably less expensive than determination of 45Ca release from bones previously labeled with 45Ca; furthermore, with neonatal mouse calvaria both total calcium and 45Ca release give equivalent results when experiments are assayed by both methods (12, 16, 17, 19 , and results described below). In addition, morphological scoring of the extent of bone resorption, which reflects both release of calcium and degradation of matrix, also correlates well with total medium calcium concentration and 45Ca release into the medium (12 and results described below).
Measurement of total medium calcium. Total calcium concentration in the medium was determined with a Coming Model 940 calcium analyzer (Coming Scientific Instruments, Medfield, Mass.). Interference with the determination of medium calcium concentration by this method was observed with unincubated medium containing 10.0 ,g/ml A23187. At this concentration the observed calcium concentration was 0.9-1.0 mgldl lower than the same medium (vol/vol) embryo extract was included in the medium, a remodeling bone culture system was obtained, permitting both bone resorption and formation. When embryo extract was omitted from the medium (as in the present studies), however, no bone formation was observed and the cultures were used exclusively for studying resorption. without A23187. No correction for this interference was made, since the amount of A23187 remaining in the medium after incubation with the calvaria was not known. There was no change in observed calcium concentration when medium contained A23187 at concentrations of 1.0 ,ug/ml or lower.
Measurement of 45Ca release from calvaria. When 45Ca release from bone was used to determine the extent of bone resorption, the method was that described by Tashjian et al. (16) . Mice were injected with 10 uCi of 45Ca at age 1 day. At 4 days of age the calvaria were removed and placed in culture. The bones were incubated in control medium for 24 h, this medium was then replaced with fresh control or treatment medium, and the incubation continued an additional 48 h. Total medium 40Ca was determined as described above. At each sampling period, 45Ca released into the medium was also determined by counting 100-gl aliquots in Bray's scintillation fluid in a liquid scintillation spectrometer.
Morphological scoring of bone resorption. The extent of bone resorption was evaluated morphologically by the basic scoring system described previouisly (12, 15) . The extent of resorption is indicated by a score for the frontal bone and for each of the two parietal bones, reflecting the relative areas of each resorbed. The frontal bone is scored from 0 for no resorption to 6 for complete resorption, and each of the parietal bones is scored from 0 to 4. Because this is a subjective procedure and reliable scoring depends on experience with this technique, the scoring of our experiments was kindly performed by Mr. Steven Isley (Department of Periodontology, Harvard School of Dental Medicine), without knowledge of the treatment groups or the order of samples. The raw scores for each of the three bones were summed to yield a single score (maximum possible 14) for each calvarium.
Measurement of cyclic AMP. Freshly dissected calvaria were placed in Oxman's modification of Eagle's minimal essential medium without protein supplementation (two bones in 0.5 ml). After preincubation for 20 min, 50 ,ul control or treatment medium was added and the incubation continued for 20 min. The bones were removed and rapidly homogenized in 1.0 ml of ice-cold 5% (wt/vol) trichloroacetic acid. The medium was collected, placed in a boiling water bath for 5 min, and frozen. The bone homogenate was centrifuged to remove precipitated protein, and after adjustment to 0.1 N in HCI, extracted five times with 5 vol of water-saturated diethvl ether. Residual ether was removed by placing in a boiling water bath for 5 min; the solution was then lyophilized and resuspended in distilled water. Cyclic AMP content of bone extracts anid unextracted medium were determined b1 the cyclic AMP protein binding assay described by Gilman (21) . The cAMPdependent protein kinase and protein-kinase inhibitor were prepared from rabbit muscle by the procedures described by Gilman for bovine muscle (21) . Digestion of cvclic AMP was performed by incubating 3':5'-cyclic nucleotide phosphodiesterase from beef heart with unknown samples suspended in 2 mM MgCl2, 25 mM Tris-HCl, pH 7.5, at a concentration of 0.04 U/ml for 4 h at 30°C; the incubation tubes were then placed in a boiling water bath for 5 min, cooled, and assayed. Additional control incubations of buffer alone or cvclic AMP standard with and without the cyclic nucleotide phosphodiesterase, or with the phosphodiesterase added immediately before the boiling-water bath, were also performed. in exp. 8, although yielding a significant stimulation of resorption (P < 0.05) by both criteria, was not repeated in exp. 9a, in which the same lot of A23187 was used and appears to be an aberrant group. The concentrations of A23187 tested ranged between 1 nM and 20 ,M (0.5 ng/ml-10.0 Aug/ml). Similar experiments performed with X-537A likewise showed no stimulation of bone resorption over the same concentration range (data not shown).
Experiments were then performed to determine whether the ionophores could potentiate bone resorption stimulated by submaximal doses of PTH. The results of experiments with A23187, given in Table II, show no potentiation by A23187 with concentrations between 10 nM and 1 ,uM (5 ng/ml-0.5 ug/ml).
Also shown in Table II are results from exp. 4 Inihibition of botne resorption by A23187 and X-537A. As shown above, the ionophore A23187 alone did not stimulate bone resorption, nor did it potentiate PTH-stimulated bone resorption. Similar results were obtained with X-537A. Instead, we observed a dose-dependent inhibition of stimulated bone resorption (Fig. 1) . Fig. 1 also shows that A23187 was four to five times more potent than X-537A. The concentrations of ionophores used in this experiment were comparable to those used in other systems (2) (3) (4) (5) where the ionophores were shown to mimic the action of physiologic stimuli.
Results presented in Fig. 2 show that A23187 inhibited bone resorption induced not only by PTH, but also by PGE2, phorbol myristate acetate, IBMX, and la(OH)-vitamin D3. Each of these agents stimulates bone resorption in a dose-dependent manner in this culture system.3 The concentration of each stimulator used in these experiments was at or near the maximally active dose.
Effects of brief exposure to A23187. Since the inhibitory effects described above were the result of incubations with the ionophores for days, and the uptake of calcium ion by bone observed in vivo or in vitro is a rapid, transient effect (8-11), we have also investigated the effects of brief exposure (15, 30, and 60 Incubations were performed in BSA medium. Bones were incubated without treatment for 24 h, the medium was removed, and fresh medium containing the indicated concentrations of PTH (0, 0.1, or 0.02 U/ml) or PTH (0 or 0.02 U/ml) + A23187 (0.5 or 5.0 ,ug/ml) was added. After incubation for the indicated periods of time, medium was removed from the treatment groups receiving A23187, the bones were rinsed three times with 2.0 ml of fresh control medium, and fresh medium containing the indicated concentration of PTH (0 or 0.02 U/ml) was added and the incubation continued for a total treatinent period of 48 h. Treatment groups that did not receive A23187 (0 min exposure) were incubated without a second change of medium. Statistical significance from the untreated control group is indicated by: * (P < 0.05); t (P < 0.01); or § (P < 0.001). (Table III) . Significant inhibition of the PTH-stimulated resorption was not observed in these short-term exposures to ionophore, due to reversibility of the inhibition as described below.
Medium calcium concentration and inhibition by the ionophores. Since the ionophores were being used to evaluate the role of calcium in the initiation of PTH-stimulated bone resorption, we investigated the effect of medium calcium concentration on the observed inhibition of resorption by the ionophores. Free calcium ion in the medium was complexed with EGTA to decrease the available calcium ion activity, or the available calcium ion activity was increased by the addition of CaCl2. The results of experiments performed with these modified media are shown in Table IV . The inhibitory effect of A23187 on PTH-stimulated bone resorption was observed in both of the modified media, indicating that the observed inhibition was not critically dependent on the medium calcium concentration.
Reversal of inhibition by the ionophores. To rule out the possibility that the observed inhibition of bone resorption was due to irreversible damage to the bone at the ionophore concentrations used, experiments were performed to determine the reversibility of the ionophore effect. Incubations were performed in the presence of PTH or A23187 plus PTH, the medium was then removed, the bones were rinsed thoroughly, medium containing the 1332second treatment (PTH or A23187 plus PTH) was added, and the incubation was continued. The results show that the inhibitory effect of A23187 was reversible even after 24 h of treatment (Fig. 3) . Similar results were also obtained after 5 h of treatment with A23187 and in similar experiments with X-537A (data not shown). These findings indicate that irreversible damage to the bones is not responsible for the effects observed with the ionophores.
Effects ofA23187 on bone resorption as determined by three different methods. Because A23187 and X-537A were selected for these studies on the basis of their ability to act as calcium ionophores, it was necessary to demonstrate that the results were not due to an effect on bulk calcium equilibrium between bone and medium, unrelated to bone resorption. Experiments were performed to assess bone resorption by three independent methods. The experiments were performed with calvaria labeled in vivo with 45Ca, as described in Methods. Comparisoni of the effects of calcitonin and A23187 on bone resorption stimulated by PGE2. Data are plotted as mean differences from control, and the vertical bars are SE of the mean difference for groups of four bones. All groups were incubated with control heat-inactivated serum medium for the first 24 h (indicated as washout), and the medium was replaced vith fresh medium containing the indicated treatments and inctubated for an additional 72 h. Aliquots of medium (0.2 ml) were removed at 24-h intervals for determination of medium calcium concentration. The treatment groups contained: PGE2 (0.1 ,ug/ml) (0); A23187 (1.0 ,g/ml) (V); human calcitonin (hCT) (0.1 ,glml) (O); PGE2 (0.1 ug/ml) + A23187 (1.0 ,tg/ml) (0); PGE2 (0.1 ug/ml) + hCT (0.1 ,ug/ml) (A); and PGE2
(0.1 ,ug/ml) + A23187 (1.0 jug/ml) + hCT (0.1 utg/ml) (M).
Medium calcium concentrations for controls were: washout, 7.2±0.09 mg/dl; 24 h, 7.3±0.09 mg/dl; 48 h, 7.2±0.12 mg/dl; and 72 h, 7.0±0.17 mgldl.
conclude that the inhibition of stimulated bone resorption observed with A23187 and X-537A is not due to an effect on bulk calciumiii equilibrium between bonie and medium unrelated to bone resorption, but rather is fundamentally related to the resorption process itself.
Comparison of inhibition of bone resorptiotn by A23187 and calcitonin. The experiment shown in Fig. 4 compares the bone resorption-inhibitory action of A23187 with that of calcitonin, a physiologic inhibitor of bone resorption. It can be seen that the inhibition produced bv A23187 persisted as long as the ionophore was present. However, calcitonin prevented bone resorption for approximately 24 h, after which resorption resumed, despite the continued presence of the hormone, and proceeded at a rate similar to that of bones exposed to PGE2 alone. This phenomenon has been observed previously by Wener et al. and has been termed "escape" (23) .
In other experiments (data not shown), the inhibitory effect of A23187 persisted for as long as 96 h in the continued presence of the ionophore. Furthermore, calcitonin consistently produced a small but significant reduction in medium calcium concentration, due to net calcium uptake by the bones, whereas this effect was not seen with the ionophores. Lastly, when calcitonin and A23187 were tested together, the ionophore did not prevent the uptake of calcium due to calcitonin but did prevent escape.
Effect of late addition of the ionophores. Further experiments were performed to determine whether the ionophores inhibited PTH-stimulated resorption only when added together with the hormone, which might be the case if an early event in the stimulation of resorption, such as PTH-induced RNA or protein synthesis, was inhibited by the ionophores, or whether the ionophores could also inhibit after stimulation of resorption had been initiated. The data shown in Fig. 5A were obtained with heat-inactivated serumil medium, and indicate that although calcitonin produced a complete, buit transient, inhibition of bone resorptioni, the ionophores, at concentrations piroduciing complete inhibition when added at the samiie time as PTH (Figs. 1 and 2 ), or PGE2 (Fig. 4) reduced the rate of resorption only slightly when adlded 24 h after PTH. When this same experiment was perfornmed in BSA medium, however, both calcitonin and the ionophores completely inhibited the resorption (Fig. 5B) . This difference in the effects of the ionophores and calcitonin in the two media was repeated with identical results. It was also observed in experiments using different lots of the two media. At the present time the basis for this differential effect of the media with respect to the action of the ionophores is not known. Unfortunately, the finding of both of the possible results complicates the interpretation of the experiment. Since complete inhibition of previously stimulated resorption is obtained in the BSA medium, it appears that the ionophores mav act after the initial events involved in the stimulation of bone resorption. This interpretation must be considered tentative, however, until the differential effects of the two media are understood.
Effects oni cyclic AMP accumulation. Another possible site of action for the inhibitory effect of the ionophores was the adenylate cyclase-cyclic AMP system, which is stimulated by PTH (24) and inhibited in membrane preparations by elevated calcium ion concentrations (25) Unexpectedly, we have found that these ionophores are potent inhibitors of bone resorption stimulated by a wide variety of compounds. The results presented suggest that the ionophores inhibit bone resorption by acting at a locus distal to the initial site of hormone binding to receptor and the stimulation of cyclic AMP accumulation, and common to all of the agents tested. In several respects the inhibition of bone resorption by the ionophores is similar to the effect of diphenylhydantoin, reported to inhibit PTH-and 25-hydroxycholecalciferol-stimulated bone resorption without affecting the action of PTH on cyclic AMP accumutlation (28) .
The inhibition of bone resorption by the ionophores differs from that of calcitonin: (a) by not exhibiting the escape from inhibition characteristic of calcitonin; (b) by not stimulating cyclic AMP accumulation in bone; (c) by not causing a measurable net movement of calcium into bone; and (d) by failing to inhibit completely bone resorption previously stimllulated by PTH in heat-inactivated serum medium (although inhibition was complete in BSA medium).
The data presented in Table V show that the effects of the ionophores are not due to actions on bulk calcium equilibriumii between bone and medium unrelated to bone resor-ption, since three independent methods for assessing the extent of bone resorption all showed inhibition of bone resorption by A23187. Other studies (2) (3) (4) (5) that employed divalent cation ionophores for investigating the role of calcium ion in various physiological events have used incubations from minutes up to 2 h, while the inhibitory effects observed in the present investigation occur over 1-3 days. However, the lack of significant stimulation or potentiation of bone resorption by the ionophores was not due solely to the length of inctubation with the ionophores, since brief (15-60 min) exposure to the ionophores either with or without submaximal doses of PTH also had no effect on the extent of resorption observed.
A23187 and X-537A were used in these studies because of their ability to bind and transport calcium. However, because both ionophores have been shown to transport monovalent cations as well, it is possible that the effect observed is due to the movement of ions other than calcium (7, (29) (30) (31) (32) (33) . Further studies will be required to investigate this possibility.
Contrary to the results presented here, Dziak and Stem (34) have reported that A23187 at concentrations of 0.1, 0.3, and 1.0 gg/ml increased release of 45Ca from prelabeled fetal rat long bones in culture, which they interpret as evidence for stimulation of bone resorption. Higher concentrations (3.0 and 10.0 gg/ml) had no effect. Because of this report we have retested the same lot of A23187 used in their studies at the same concentrations and have observed consistent, dose-related inhibition of bone resorption by all three measurement techniques. Thus at present we have no explanation for the discrepancy in results.
From the data presented in this communication, we conclude that the ionophores A23187 and X-537A do not stimulate bone resorption or potentiate the effects of PTH or other stimulators of bone resorption in cultured mouse calvaria. At no concentration of the ionophores have we observed a consistent stimulation of bone resorption under a variety of experimental conditions. We have consistently found inhibition of bone resorption stimulated by a wide variety of compounds. The mechanism by which the ionophores inhibit bone resorption in a reversible, dose-dependent manner is not known at present, but we believe that these compounds may be useful tools for investigating bone metabolism.
